Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK
Kono et al., Antiviral Research, 77:2, February 2008, 150-152, 10.1016/j.antiviral.2007.10.011 (In Vitro)
Kono et al., Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine:.., Antiviral Research, 77:2, February 2008, 150-152, 10.1016/j.antiviral.2007.10.011 (In Vitro)
Dec 2007   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
CQ significantly decreased viral replication of HCoV-229E at concentrations lower than in clinical usage. CQ affects the activation of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK). p38 MAPK inhibitor, SB203580, inhibits CPE induced by HCoV-229E infection and viral replication.
14 In Vitro studies support the efficacy of HCQ [Andreani, Clementi, Dang, Delandre, Faísca, Hoffmann, Liu, Ou, Purwati, Sheaff, Wang, Wang (B), Yao, Yuan].
Kono et al., 4 Dec 2007, peer-reviewed, 6 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Available online at www.sciencedirect.com Antiviral Research 77 (2008) 150–152 Short communication Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK Masakazu Kono a,b , Koichiro Tatsumi b , Alberto M. Imai a , Kengo Saito a , Takayuki Kuriyama b , Hiroshi Shirasawa a,∗ a Department of Molecular Virology, Chiba University School of Medicine, 1-8-1 Inohana, Chiba 260-8670, Japan b Department of Chest Medicine, Chiba University School of Medicine, 1-8-1 Inohana, Chiba 260-8670, Japan Received 13 July 2007; accepted 17 October 2007 Abstract The antiviral effects of chloroquine (CQ) on human coronavirus 229E (HCoV-229E) infection of human fetal lung cell line, L132 are reported. CQ significantly decreased the viral replication at concentrations lower than in clinical usage. We demonstrated that CQ affects the activation of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK). Furthermore, p38 MAPK inhibitor, SB203580, inhibits CPE induced by HCoV-229E infection and viral replication. Our findings suggest that CQ affects the activation of MAPKs, involved in the replication of HCoV-229E. © 2007 Elsevier B.V. All rights reserved. Keywords: Coronavirus; 229E; Chloroquine; p38; MAPK; ERK Chloroquine (CQ), a diprotic weak base that increases the pH of acidic vesicles, has been used for the treatment of malaria and inflammatory diseases, such as rheumatoid arthritis. CQ has antimicrobial effects even against viruses, such as human immunodeficiency virus type 1 (HIV-1) and SARS-CoV (Sperber et al., 1993; Savarino et al., 2003; Vincent et al., 2005). However, the inhibitory effect on SARS-CoV is inactive in vivo (Barnard et al., 2006), and the detailed mechanisms underlying the antimicrobial and anti-inflammatory effects of CQ remain poorly understood. Coronavirus, an enveloped virus, enters the cytoplasm by endocytosis and matures in the membrane transport system, such as the trans-Golgi network (TGN) (Nauwynck et al., 1999; Ng et al., 2003). ER stress caused by Japanese encephalitis virus infection induces the activation of p38 mitogen-activated protein kinase (MAPK) and host cell apoptosis (Su et al., 2002). MAPKs including ERK, JNK and p38 are involved in cell death (Xia et ∗ Corresponding author. E-mail address: sirasawa@faculty.chiba-u.jp (H. Shirasawa). 0166-3542/$ – see front matter © 2007 Elsevier B.V. All rights reserved. doi:10.1016/j.antiviral.2007.10.011 al., 1995) play a crucial role in infection of coronaviruses, such as mouse hepatitis virus and SARS-CoV (Banerjee et al., 2002; Kopecky-Bromberg et al., 2006). CQ inhibits the activation of p38 MAPK and cytokine production caused by CpG DNA (Yi and Krieg, 1998). ERK, another MAPK associated with cell proliferation (Xia et al., 1995), is also affected by virus infection and CQ (Pleschka et al., 2001; Weber et al., 2002). In this study, we examined the correlation between CQ and the activation of p38 MAPK and ERK in human coronavirus 229E (HCoV-229E) infection, and demonstrated the involvement of p38 MAPK in the replication of HCoV-229E. To examine the effect of CQ on the viral replication, virus in the supernatants was quantified by measuring the HCoV-229E RNA by reverse transcription (RT) realtime PCR. RNA from culture supernatants was extracted by using the QIAamp Viral RNA Mini Kit (QIAGEN) according to manufacturer’s instructions and used for..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit